Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 49, 2020 - Issue 2
Submit an article Journal homepage
309
Views
3
CrossRef citations to date
0
Altmetric
Short Communications

Frequency, characteristics, and clinical determinants of ‘prodrome’ in familial Mediterranean fever patients

H BabaogluFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, TurkeyCorrespondence[email protected]
,
N AtasFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
O VaranFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
H SatisFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
R Bilici SalmanFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
A GulerFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
H KaradenizFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
MA OzturkFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
S HaznedarogluFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
,
B GokerFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
&
A TufanFaculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey
 show all
Pages 154-158 | Accepted 27 Jun 2019, Published online: 03 Sep 2019

References

  • Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009;27:621–68.
  • Aksentijevich ICM, Deng Z. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997;90:797–807.
  • Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006;103:9982–7.
  • Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009;146:467–78.
  • Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, et al. Evidence-based recommendations for the practical management of familial Mediterranean fever. Semin Arthritis Rheum 2013;43:387–91.
  • Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, et al. Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Semin Arthritis Rheum 2004;33:273–82.
  • Cvetkovic RS, Keating G. Anakinra. BioDrugs 2002;16:303–11; discussion 13–4.
  • Erden A, Batu ED, Sari A, Sonmez HE, Armagan B, Demir S, et al. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever? Clin Exp Rheumatol 2018;36:97–102.
  • Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006;33:1089–92.
  • Milano AM. Familial Mediterranean fever associated with menstruation. Efficacy of intermittent colchicine therapy. Am J Gastroenterol 1981;76:363–4.
  • Wright DG, Wolff SM, Fauci AS, Alling DW. Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med 1977;86:162–5.
  • Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85.
  • Babaoglu H, Varan O, Kucuk H, Atas N, Satis H, Salman R, et al. On demand use of anakinra for attacks of familial Mediterranean fever (FMF). Clin Rheumatol 2019;38:577–81.
  • Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 2011;70:2155–8.
  • Grimwood C, Despert V, Jeru I, Hentgen V. On-demand treatment with anakinra: a treatment option for selected TRAPS patients. Rheumatology (Oxford) 2015;54:1749–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.